Dose Finding Study Of Oral Eltrombopag In Patients With Sarcoma Receiving Adriamycin And Ifosfamide

Clinical trial NCT00358540 · COMPLETED

Trial details

NCT number: NCT00358540
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Thrombocytopaenia

Start date: 2006-06-01
Primary completion: 2010-10-22
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.